Number of shares outstanding for Agios Pharmaceuticals (AGIO)

Number of shares outstanding as of December 2025 : 58,139,277

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 58,139,277. At the end of 2025 the company had 58,139,277 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Agios Pharmaceuticals from 2012 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	58.13 M	2.11%
2024	56.93 M	2.04%
2023	55.8 M	1.75%
2022	54.84 M	0.94%
2021	54.33 M	-21.56%
2020	69.27 M	8.32%
2019	63.94 M	9.9%
2018	58.18 M	19.31%
2017	48.77 M	15.82%
2016	42.11 M	11.82%
2015	37.66 M	7.23%
2014	35.12 M	12.74%
2013	31.15 M	33.19%
2012	23.38 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Xencor XNCR	74,413,000	27.99%	🇺🇸 USA
Exelixis EXEL	268,421,000	361.69%	🇺🇸 USA
Pfizer PFE	5,685,000,000	9,678.24%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	192,032,000	230.30%	🇺🇸 USA
GlaxoSmithKline GSK	2,017,000,000	3,369.26%	🇬🇧 UK
Eli Lilly LLY	895,841,000	1,440.85%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions